Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling

Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling

Saved in:

Bibliographic Details
Main Authors:	Cordelia Dunai, Smita S. Iyer, William J. Murphy
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Immunology
Subjects:	immunology virology SARS-CoV-2 mouse models preclinical models
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1548624/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antibody-dependent enhancement of SARS-CoV-2, the impact of variants and vaccination
by: Swapna Thomas, et al.
Published: (2025-12-01)

Sequential SARS-CoV-2 mRNA Vaccination Induces Anti-Idiotype (Anti-ACE2) Antibodies in K18 Human ACE2 Transgenic Mice
by: Craig P. Collins, et al.
Published: (2025-02-01)

RhCMV reactivation in SARS-CoV-2 infected aged rhesus macaques
by: Jamin W. Roh, et al.
Published: (2025-06-01)

Sex differences in adenosine deaminase activity associate with disparities in SARS-CoV-2 innate immunity
by: Priyanka Saminathan, et al.
Published: (2025-05-01)

Humanized Major Histocompatibility Complex Transgenic Mouse Model Can Play a Potent Role in SARS-CoV-2 Human Leukocyte Antigen-Restricted T Cell Epitope Screening
by: Jiejie Zhang, et al.
Published: (2025-04-01)

Pulmonary lymphoid tissue induced after SARS-CoV-2 infection in rhesus macaques
by: Zhong-Min Ma, et al.
Published: (2025-03-01)

Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines
by: David Hodgson, et al.
Published: (2025-03-01)

Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection
by: Raveen Rathnasinghe, et al.
Published: (2020-01-01)

MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies
by: Olubukola M. Abiona, et al.
Published: (2025-02-01)

A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge
by: Xiangchuan He, et al.
Published: (2021-01-01)

SARS-CoV-2 Immunization Index in the Academic Community: A Retrospective Post-Vaccination Study
by: Keltyn Oliveira, et al.
Published: (2024-11-01)

In vivo determination of protective antibody thresholds for SARS-CoV-2 variants using mouse models
by: Peilan Wei, et al.
Published: (2025-12-01)

Structural and functional analyses of SARS-CoV-2 Nsp3 and its specific interactions with the 5’ UTR of the viral genome
by: Sofia Lemak, et al.
Published: (2025-08-01)

A four-week study on the toxicity of repeated intramuscular administration of plant-based BA-CoV2-0301 vaccine against SARS-CoV-2 in Sprague-Dawley rats
by: Sang-Jin Park, et al.
Published: (2025-12-01)

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
by: Kyle Rosenke, et al.
Published: (2020-01-01)

An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variantResearch in context
by: Ryuta Uraki, et al.
Published: (2025-07-01)

Inhibition of dimeric SARS-CoV-2 Mpro displays positive cooperativity and a mixture of covalent and non-covalent binding
by: Krishna M. Padmanabha Das, et al.
Published: (2025-07-01)

SARS-CoV-2, influenza, HRSV and other respiratory pathogens during the post-COVID-19 era: Epidemic circulation in Italy in the 2023/2024 season
by: Serena Marchi, et al.
Published: (2025-11-01)

Ensemble modeling of SARS-CoV-2 immune dynamics in immunologically naïve rhesus macaques predicts that potent, early innate immune responses drive viral elimination
by: Catherine Byrne, et al.
Published: (2024-11-01)

Interaction of SARS-CoV-2 and SARS-CoV-2 vaccines with renin angiotensin aldosterone system, clinical outcomes, and angiotensin (1-7) as a physiological treatment recommendation: hypothesis and theory article
by: Ali Rıza Aktaş
Published: (2025-07-01)

Enhanced reverse zoonotic potential and immune evasion by omicron JN.1 variant
by: Jiaxin Hu, et al.
Published: (2025-07-01)

Impact of air pollution and occupational inhalation exposures on neurodegenerative disorders: An epigenetic perspective
by: Paola Monti, et al.
Published: (2025-07-01)

Modelling and investigating memory immune responses in infectious disease. Application to influenza a virus and sars-cov-2 reinfections
by: Mathilde Massard, et al.
Published: (2025-03-01)

The Intersection of SARS-CoV-2 and Diabetes
by: Jacob H. Nichols, et al.
Published: (2025-06-01)

Driving consistency: CEPI-Centralized Laboratory Network’s conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines
by: Ali Azizi, et al.
Published: (2024-12-01)

The GPR4 antagonist NE-52-QQ57 increases survival, mitigates the hyperinflammatory response and reduces viral load in SARS-CoV-2-infected K18-hACE2 transgenic mice
by: Xin-Jun Wu, et al.
Published: (2025-07-01)

SARS-CoV-2 and Coronaviruses: Understanding Transmission, Impact, and Strategies for Prevention and Treatment
by: Seyede Nafise Tabatabaei, et al.
Published: (2025-02-01)

Coronavirus replicase epitopes induce cross-reactive CD8 T cell responses in SARS-CoV-2-naive people with HIV-1
by: Katja G. Schmidt, et al.
Published: (2025-03-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome
by: Cansu Cimen Bozkus, et al.
Published: (2025-08-01)

Identification of SARS-CoV-2 variants of concern in vaccine-breakthrough infections
by: Baha Abdalhamid, et al.
Published: (2022-04-01)

Genomic surveillance of SARS-CoV-2 variants using pooled WGS
by: Inho Park, et al.
Published: (2025-04-01)

Adjuvants to the S1-subunit of the SARS-CoV-2 spike protein vaccine improve antibody and T cell responses and surrogate neutralization in mice
by: William Becker, et al.
Published: (2024-11-01)

Influenza vaccination as a prognostic factor of humoral IgA responses to SARS-CoV-2 infection
by: Barbara Poniedziałek, et al.
Published: (2024-02-01)

Methylene Blue Has Strong Extracellular Virucidal Activity Against a SARS-CoV-2-Related Pangolin Coronavirus with No Intracellular or In Vivo Efficacy
by: Lai Wei, et al.
Published: (2024-11-01)

Reply to “Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection”
by: Jefferson M. Jones, et al.
Published: (2025-02-01)

Aggravated pneumonia and diabetes in SARS-CoV-2 infected diabetic mice
by: Qing Huang, et al.
Published: (2023-12-01)

SARS-CoV-2 mRNA vaccines confer protection in diet-induced obese mice despite altered immune cell profiles in the lung
by: Katherine S. Lee, et al.
Published: (2025-07-01)

Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV
by: Vahid Rajabali Zadeh, et al.
Published: (2025-05-01)

A rare case of macroamylasemia in a patient with SARS-CoV-2 infection
by: Tilan Aponso, et al.
Published: (2025-02-01)